Non-animal approaches for photoallergenicity safety assessment: Needs and perspectives for the toxicology for the 21st century.

Allergy In vitro testing Non-animal approaches Phototoxicity Skin toxicity

Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 06 03 2023
revised: 07 09 2023
accepted: 28 09 2023
medline: 4 12 2023
pubmed: 8 10 2023
entrez: 7 10 2023
Statut: ppublish

Résumé

Certain chemicals and/or their byproducts are photoactivated by UV/VIS and trigger a dermal allergenic response, clinically recognized as photoallergic contact dermatitis (PACD). It is important to identify the chemicals which are potentially photoallergenic, not only for establishing the correct differential diagnosis between PACD and other photodermatoses, but also as causative agents which should be avoided as a preventative measure. Moreover, materials with photoallergenic properties need to be correctly identified to allow thorough safety assessments for their use in finished products (e.g. cosmetics). Development of methods for predicting photoallergenicity potential of chemicals has advanced at slow pace in recent years. To date, there are no validated methods for photosensitisation potential of chemicals for regulatory purposes, although it remains a required endpoint in some regions. The purpose of this review is to explore the mechanisms potentially involved in the photosensitisation process and discuss the methods available in the literature for identification of photosensitisers. The review also explores the possibilities of further research investment required to develop human-relevant new approach methodologies (NAMs) and next generation risk assessment (NGRA) approaches, considering the current perspectives and needs of the Toxicology for the 21st Century.

Identifiants

pubmed: 37805107
pii: S0273-2300(23)00167-8
doi: 10.1016/j.yrtph.2023.105499
pii:
doi:

Substances chimiques

Allergens 0
Cosmetics 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105499

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Marize Campos Valadares reports financial support was provided by Conselho Nacional de Desenvolvimento Científico e Tecnológico.

Auteurs

Renato Ivan de Ávila (RI)

Unilever Safety and Environmental Assurance Centre (SEAC), Colworth Science Park, Sharnbrook, Bedfordshire, UK; Laboratory of Education and Research in in Vitro Toxicology (Tox in), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil. Electronic address: Renato.de-Avila@unilever.com.

Maja Aleksic (M)

Unilever Safety and Environmental Assurance Centre (SEAC), Colworth Science Park, Sharnbrook, Bedfordshire, UK.

Bin Zhu (B)

Unilever Research and Development Centre, Shanghai, China.

Jin Li (J)

Unilever Safety and Environmental Assurance Centre (SEAC), Colworth Science Park, Sharnbrook, Bedfordshire, UK.

Ruth Pendlington (R)

Unilever Safety and Environmental Assurance Centre (SEAC), Colworth Science Park, Sharnbrook, Bedfordshire, UK.

Marize Campos Valadares (MC)

Laboratory of Education and Research in in Vitro Toxicology (Tox in), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH